CRDA.L vs IOSP
CRDA.L: A leading provider of sustainable specialty chemicals and performance ingredients for the beauty, pharmaceutical, and agriculture industries. IOSP: Innospec is a global specialty chemical company providing performance-enhancing additives and ingredients for the fuel, energy, and personal care markets.
Side-by-side fundamentals
| Metric | CRDA.L | IOSP | Edge |
|---|---|---|---|
| Price | £33.38 | $97.69 | |
| Market cap as of 2026-07-31 (share count; price 2026-10-08) | n/a | $2.4B | |
| P/E | 75.18 | 19.95 | IOSP lower |
| Net margin | +3.8% | +6.6% | IOSP higher |
| Gross margin | +43.9% | +27.7% | CRDA.L higher |
| Operating margin FY2025, SEC XBRL | n/a | +7.3% | |
| ROE | +2.9% | +8.8% | IOSP higher |
| ROA FY2025, SEC XBRL | n/a | +6.4% | |
| Debt / equity as of 2026-09-02 | n/a | 0.00 | |
| Revenue growth (YoY) as of 2026-09-02 | n/a | +2.9% | |
| Revenue CAGR (3y) SEC XBRL | n/a | -3.3% | |
| Dividend yield as of 2026-09-02 | n/a | +2.0% | |
| Dividend streak (yrs) SEC XBRL | n/a | 13 | |
| Beta as of 2026-09-02 | n/a | 0.76 | |
| 1-year return | +16.2% | +24.4% | IOSP higher |
Fundamentals: SEC XBRL company filings and annual report filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.